Loading...
Palisade Bio, Inc.
PALI•NASDAQ
Healthcare
Biotechnology
$1.16
$0.05(4.50%)
Palisade Bio, Inc. (PALI) Financial Performance & Income Statement Overview
Review Palisade Bio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
-13.69%
↓ 13.69%
Net Income Growth
-17.38%
↓ 17.38%
Operating Cash Flow Growth
-9.52%
↓ 9.52%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-178.91%
↓ 178.91%
ROIC
-249.33%
↓ 249.33%
Palisade Bio, Inc. (PALI) Income Statement & Financial Overview
Review Palisade Bio, Inc.'s (PALI) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $1000.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$1000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $950000.00 | $2.08M | $2.14M | $2.63M |
| SG&A Expenses | $1.36M | $1.30M | $1.46M | $1.58M |
| Operating Expenses | $2.31M | $3.38M | $3.59M | $4.21M |
| Total Costs & Expenses | $0.00 | $3.38M | $3.59M | $4.21M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$1000.00 | $3000.00 | $6000.00 | $2000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $1000.00 | $1000.00 |
| EBITDA | -$2.31M | -$3.34M | -$3.48M | -$4.08M |
| EBITDA Ratio | ||||
| Operating Income | -$2.31M | -$3.38M | -$3.59M | -$4.21M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $80000.00 | $38000.00 | $106000.00 | $131000.00 |
| Income Before Tax | -$2.23M | -$3.34M | -$3.49M | -$4.08M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.23M | -$3.34M | -$3.49M | -$4.08M |
| Net Income Ratio | ||||
| EPS | -$0.47 | -$2.36 | -$2.32 | -$3.32 |
| Diluted EPS | -$0.47 | -$2.36 | -$2.32 | -$3.32 |
| Weighted Avg Shares Outstanding | $4.80M | $1.20M | $1.50M | $1.23M |
| Weighted Avg Shares Outstanding (Diluted) | $4.80M | $1.20M | $1.50M | $1.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan